You are here

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Successful liver transplantation in common variable immune deficiency with reversal of hepatopulmonary syndrome
  1. Ross Apostolov1,
  2. Marie Sinclair1,
  3. Julie Lokan2 and
  4. Peter Angus1
  1. 1 Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia
  2. 2 Department of Pathology, Austin Health, Heidelberg, Victoria, Australia
  1. Correspondence to Dr Ross Apostolov, ross.apostolov1{at}gmail.com

Abstract

Common variable immune deficiency (CVID) is a primary immunodeficiency disorder that is associated with abnormal liver function tests, however advanced liver disease is uncommon. Hepatopulmonary syndrome (HPS) is a rare but debilitating complication of CVID-associated liver disease. We report a case of CVID complicated by HPS that was successfully treated with orthotopic liver transplant, with the patient recovering to normal hepatic function and successfully weaning off domiciliary oxygen post-transplantation.

  • portal hypertension
  • immunology
  • transplantation

https://doi.org/10.1136/bcr-2018-226095

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors RA, MS and PA were involved in the patient’s care and conceptualised the case report. RA and MS performed the initial draft of the manuscript. JL provided and annotated the pathology figures and edited the manuscript sections that described biopsy findings. PA made significant edits to the initial draft of the manuscript. All authors have reviewed and approved the final manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Obtained.